Dr. O’Loughlin is a Professor in the School of PublicHealth at the University of Montreal School. She is a Tier 1 Canada ResearchChair in the Early Determinants of Chronic Disease, a member of the Carrefour de l’innovation et del’évaluation en santé at the University ofMontreal Hospital Research Center (CRCHUM), an elected member of the AmericanAcademy of Pediatrics Tobacco Consortium, and a member of the Canadian Academyof Health Sciences. Her team is housed at the CRCHUM and in addition to localresearchers Dr. O’Loughlin has ongoing collaborations nationally andinternationally. Her research has focused on increased understanding of therelative importance of genetic, psychosocial, behavioral and environmentaldeterminants of the childhood risk for adult chronic disease. She heads twopediatric cohort investigations (i.e., the Nicotine Dependence in Teens (NDIT)Study and AdoQuest) and she is a co-investigator on another four. Her researchoutput includes over 300 publications and over 500 presentations at local,national and international conferences. A key indicator of how her work isinfluential, is its citation in “Preventing Tobacco Use Among Youth and YoungAdults: A Report of the Surgeon General, 2012” and “A Report of the SurgeonGeneral: How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis forSmoking-Attributable Disease, 2010.” Her research is also cited in an INSPQsubmission to the Quebec government on proposed legislative changes to theQuebec Tobacco Control Act. Overall Dr. O’Loughlin’s work exemplifiesinterdisciplinary research that is well-grounded in public health, itdemonstrates leadership in child and adolescent research, and it provides the“cells to society” underpinnings for furthering early prevention of adult chronicdisease.